Recent findings of long-chain n-3 polyunsaturated fatty acids (LCn-3 PUFAs) on atherosclerosis and coronary heart disease (CHD) contrasting studies in Western countries to Japan-Reference-Cited by-同舟云学术

Recent findings of long-chain n-3 polyunsaturated fatty acids (LCn-3 PUFAs) on atherosclerosis and coronary heart disease (CHD) contrasting studies in Western countries to Japan

Published:2015-11 Issue:8 Volume:25 Page:717-723
ISSN:1050-1738
Container-title:Trends in Cardiovascular Medicine
language:en
Short-container-title:Trends in Cardiovascular Medicine

Author:

Sekikawa Akira,Doyle Margaret F.,Kuller Lewis H.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference40 articles.

1. Epidemiological studies in the upernavik district, greenland. Incidence of some chronic diseases 1950-1974;Kromann;Acta Med Scand,1980

2. U.S. adults are not meeting recommended levels for fish and omega-3 fatty acid intake: results of an analysis using observational data from NHANES 2003-2008;Papanikolaou;Nutr J,2014

3. Marine omega-3 fatty acids and coronary heart disease;Calder;Curr Opin Cardiol,2012

4. Omega-3 Fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events;Mozaffarian;J Am Coll Cardiol,2011

5. N–3 fatty acids in cardiovascular disease;De Caterina;N Engl J Med,2011

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating plasma phospholipid fatty acid levels as a biomarker of habitual dietary fat intake: The INTERMAP/INTERLIPID Study;Journal of Clinical Lipidology;2023-01

2. Buckwheat: Properties, Beneficial Effects and Technological Applications;Reference Module in Food Science;2023

3. The Effect of Cardiac Rehabilitation on Lipid Levels in Patients with Coronary Heart Disease. A Systematic Review and Meta-Analysis;Global Heart;2022-11-29

4. Docosahexaenoic Acid Counteracts the Hypoxic-Induced Inflammatory and Metabolic Alterations in 3T3-L1 Adipocytes;Nutrients;2022-11-01

5. Evaluation of efficacy and safety of combined rosuvastatin and atorvastatin in treating with coronary heart disease;Medicine;2021-06-18